Gary Loeb Sells 400 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Gary Loeb also recently made the following trade(s):

• On Monday, May 11th, Gary Loeb sold 400 shares of Intuitive Surgical stock. The shares were sold at an average price of $446.95, for a total value of $178,780.00.

Intuitive Surgical Price Performance

ISRG opened at $412.90 on Friday. The business has a fifty day simple moving average of $443.95 and a 200 day simple moving average of $496.79. The company has a market capitalization of $146.23 billion, a PE ratio of 50.05, a price-to-earnings-growth ratio of 3.29 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $396.68 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.81 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Brokerage coverage remains constructive, with Intuitive Surgical carrying an average “Moderate Buy” rating and several firms reiterating bullish views. Recent commentary also lifted FY2027 EPS estimates, suggesting analysts still see solid long-term earnings growth.
• Positive Sentiment: A bullish investor thesis highlighted on social-media-driven coverage points to ongoing growth in robotic-assisted surgery demand, while prior results showed the company beating earnings and revenue expectations, reinforcing its premium growth profile.
• Positive Sentiment: Recent analysis says ISRG can offset tariff and input-cost pressure through scale, cost discipline, and rising adoption of the da Vinci 5 system, which supports the margin outlook.
• Neutral Sentiment: Two executives sold small amounts of stock under pre-arranged 10b5-1 trading plans. These sales were routine and not necessarily a negative signal, but they may still add to investor caution in the near term. Article: Intuitive Surgical (NASDAQ:ISRG) EVP Sells $169,656.00 in Stock
• Neutral Sentiment: Some recent research notes also trimmed price targets, indicating that while analysts remain broadly positive, expectations have been recalibrated lower for valuation and near-term upside.
• Negative Sentiment: The stock has been trading below its 50-day and 200-day moving averages, and one recent report noted the shares were down sharply from prior levels, reflecting ongoing valuation and sentiment pressure.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of the business. FAS Wealth Partners Inc. lifted its position in shares of Intuitive Surgical by 1.0% during the 1st quarter. FAS Wealth Partners Inc. now owns 5,282 shares of the medical equipment provider’s stock worth $2,435,000 after buying an additional 52 shares during the last quarter. Pine Valley Investments Ltd Liability Co lifted its position in shares of Intuitive Surgical by 30.0% during the 1st quarter. Pine Valley Investments Ltd Liability Co now owns 2,350 shares of the medical equipment provider’s stock worth $1,083,000 after buying an additional 543 shares during the last quarter. Evansbrook LLC lifted its position in shares of Intuitive Surgical by 5.4% during the 1st quarter. Evansbrook LLC now owns 1,651 shares of the medical equipment provider’s stock worth $761,000 after buying an additional 85 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Intuitive Surgical by 0.8% during the 1st quarter. Parallel Advisors LLC now owns 40,733 shares of the medical equipment provider’s stock worth $18,778,000 after buying an additional 321 shares during the last quarter. Finally, NewEdge Advisors LLC lifted its position in shares of Intuitive Surgical by 65.2% during the 1st quarter. NewEdge Advisors LLC now owns 42,683 shares of the medical equipment provider’s stock worth $19,676,000 after buying an additional 16,847 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ISRG shares. Evercore cut their target price on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. UBS Group cut their target price on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. Bank of America cut their target price on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a research report on Monday, May 18th. Finally, HSBC cut their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $573.63.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.